Leon E. Rosenberg
Chairman presso Talon Therapeutics, Inc.
Profilo
Leon E.
Rosenberg is currently the Non-Executive Chairman at Talon Therapeutics, Inc., Adjunct Professor at Yale University, and Professor at Princeton University.
He previously held positions as Chairman at Karo Healthcare AB, Director at Email Real Estate.com, Inc., Director at Lovelace Respiratory Research Institute, and Director at MMV Medicines for Malaria Venture.
He was also the Senior Vice President-Scientific Affairs at Bristol Myers Squibb Co. from 1997 to 1998 and the President at Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997.
Rosenberg received his undergraduate and doctorate degrees from the University of Wisconsin.
Posizioni attive di Leon E. Rosenberg
Società | Posizione | Inizio |
---|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Chairman | 01/02/2004 |
Princeton University | Corporate Officer/Principal | 01/09/1997 |
Yale University | Corporate Officer/Principal | 27/04/2011 |
Precedenti posizioni note di Leon E. Rosenberg
Società | Posizione | Fine |
---|---|---|
Email Real Estate.com, Inc. | Director/Board Member | 13/10/2004 |
BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 01/03/1998 |
Bristol-Myers Squibb Pharmaceutical Research Institute | President | 01/01/1997 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Director/Board Member | - |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Director/Board Member | - |
Formazione di Leon E. Rosenberg
University of Wisconsin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
KARO PHARMA AB (PUBL) | Health Technology |
Aziende private | 5 |
---|---|
Email Real Estate.com, Inc. | Finance |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Commercial Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
Bristol-Myers Squibb Pharmaceutical Research Institute |
- Borsa valori
- Insiders
- Leon E. Rosenberg